Algenis is a leading company specializing in the production and clinical development of bioactive molecules with medical applications. Since its establishment in 2002, our goal has been to become the forefront of microalgae molecule research. We work with sodium channel blockers that have the potential to treat various diseases and offer multiple clinical applications.

Our dedicated team of experts researches and develops bioactive molecules derived from marine microalgae, which serve as effective solutions against different pathologies. Through rigorous clinical investigations, Algenis has conducted phase I and II studies approved by the FDA. Currently, we are conducting exploratory studies for various applications.

Located in Santiago, Chile, our headquarters at Av. Zañartu 1500, Ñuñoa, serve as the center for our groundbreaking research and development. For more information about our innovative technology and products, or to get in touch with us, you can reach us at info@algenis.

com or call us at +56 9 4241 0133. © Algenis 2022. All rights reserved